Sarilumab monotherapy compared with adalimumab monotherapy for the treatment of moderately to severely active rheumatoid arthritis: An analysis of incremental cost per effectively treated patient

Marie Fournier, Chieh I. Chen, Andreas Kuznik, Clare Proudfoot, Usha G. Mallya, Kaleb Michaud

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Fingerprint

Dive into the research topics of 'Sarilumab monotherapy compared with adalimumab monotherapy for the treatment of moderately to severely active rheumatoid arthritis: An analysis of incremental cost per effectively treated patient'. Together they form a unique fingerprint.

Business & Economics

Medicine & Life Sciences

Social Sciences